Moody's Investors Service affirmed its "A2" rating on Reno, Nev.-based Renown Health, affecting $448 million of rated debt.
The affirmation is a result of several factors, including the health system's growing balance sheet, improving debt metrics, significant size, strong market position and its wide range of clinical offerings.
The outlook is stable, reflecting Moody's expectation that Renown's strong market position and the absence of debt plans will continue to grow Renown's balance sheet and improve operations.